Scientists Find New Class Of Compounds with Great Potential for Research and Drug Development, The Scripps Research Institute Study

Scientists from The Scripps Research Institute have identified a class of compounds that could be a boon to basic research and drug discovery. In a new study, published online in Nature Chemical Biology on May 15, 2011, the researchers show the new compounds powerfully and selectively block the activity of a large and diverse group of enzymes known as "serine hydrolases." Previously discovered serine hydrolase-blocking compounds have been turned into drugs to treat obesity, diabetes, and Alzheimer's disease, and are currently in testing as treatments for pain, anxiety, and depression.

Back to news